Japanese trailblaze with GHTF (Global Harmonisation Task Force) product approval format
This article was originally published in Clinica
Executive Summary
The Japanese Ministry of Health, Labour and Welfare is trialling an internationally agreed format for technical documentation used on the submission of application for new or improved medical devices. The new format has been developed by the Global Harmonisation Task Force. The MHLW's one-year pilot-study began on February 1 and the European medical device industry association, Eucomed, says it supports the ministry in "encouraging device manufacturers active in Japan to participate in this pilot study".
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.